Journal Article |
| Ruckdeschel JC. Special problems in the older cancer patient: spinal cord compression and pleural effusions. Oncology. 1992;6(2):119-23. | 1992 |
| Remick SC, Ruckdeschel JC. Extrapulmonary and pulmonary small-cell carcinoma: tumor biology, therapy and outcome. Med Pediatr Oncol. 1992;20:89-99. | 1992 |
| Ruckdeschel JC. Chemotherapy of metastatic non-small cell carcinoma of the lung. Hematol Oncol. 1992;10:25-30 | 1992 |
| Kobassa SCO, Spinetta JJ, Cohen J, Crano WD, Hatchett S, Kaplan BH, Lansky SB, Prout MN, Ruckdeschel JC, Siegel K, Wellisch DK. Social environment and social support. Cancer. 1991;67 (suppl 1):788-93. | 1991 |
| Johnson DH, Ruckdeschel JC, Keller JH, Lyman GH, Kallas GJ, MacDonald J, DeConti RC, Lee J. A randomized trial to compare intravenous and orally administered etoposide in combination with cisplatin for the treatment of small cell lung cancer. Cancer. 1991;67(suppl):245. | 1991 |
| Remick SC, Harper GR, Abdullah MA, McSharry JJ, Ross JS, Ruckdeschel JC. Metastatic breast cancer in a young patient seropositive for human immunodeficiency virus. J Natl Cancer Inst. 1991;83:447. | 1991 |
| Labrecque MS, Blanchard CG, Ruckdeschel JC, Blanchard EB. The impact of family presence on the physician cancer patient interaction. Soc Sci Med. 1991;33:1253-61. | 1991 |
| Ruckdeschel JC, Piantadosi S, and the LCSG. Quality-of-life assessment in lung surgery for bronchogenic carcinoma. Theor Surg. 1991;6:201-5. | 1991 |
| Ruckdeschel JC, Moores D, Lee JY, Einhorn LH, Mandelbaum I, Koeller J, Weiss GR, Losada M, Keller J Intrapleural therapy for malignant pleural effusions: a randomized comparison of bleomycin and tetracycline. Chest. 1991;100:1528-35. | 1991 |
| Henry DH, Beall GN, Benson CA, Carey J, Cone L, Eron LJ, Fiala M, Fischl M, Gabin S, Galpin J, Gottlieb M, Groopman JE, Hooton T, Jemsek J, Levine R, Miles S, Rinehart JJ, Rios A, Robbins W, Ruckdeschel JC, Smith J, Spruance S, Starrett B, Toney J, Zalusky R, Abels R, Bryant E, Larholt R, Sampson A, Rudnick S. Recombinant human erythropoietin in the treatment of the anemia associated with human immunodeficiency virus infection and zidovudine therapy: overview of four clinical trials. Ann Intern Med. 1991;117:739-48. | 1991 |
| Ettinger DS, Finkelstein DM, Abeloff MD, Ruckdeschel JC, Aisner SC, Eggleston JC. A randomized comparison of standard chemotherapy versus alternating chemotherapy and maintenance versus no maintenance therapy for extensive-stage small cell lung cancer: a phase III study of the Eastern Cooperative Oncology Group. J Clin Oncol.1990;8:230-40. | 1990 |
| Aisner SC, Finkelstein DM, Ettinger DS, Abeloff MD, Ruckdeschel JC, Eggleston JC. The clinical significance ofvariant-morphology small cell carcinoma of the lung. J Clin Oncol. 1990;8:402-8. | 1990 |
| Blanchard CG, Labrecque MS, Ruckdeschel JC, Blanchard EB. Physician behaviors, patient perceptions and patient characteristics as predictors of satisfaction of hospitalized adult cancer patients. Cancer. 1990;65:186-92. | 1990 |
Braun MA, Killam DA, Remick SC, Ruckdeschel JC. Lung cancer in patients seropositive for human
immunodeficiency virus. Radiology. 1990;175:341-3 | 1990 |
| Remick SC, Diamond C, Migliozzi JA, Solis O, Wagner H, Haase RF, Ruckdeschel JC. Primary central nervous system lymphoma (PCL) in patients with and without AIDS. A retrospective analysis and review of the literature. Medicine. 1990;69(6):345-60. | 1990 |
| Nelles WB, Blanchard CG, McCaffrey RJ, Ruckdeschel JC. Social supports and breast cancer: a review. J Psychosoc Oncol. 1991;9(2):21-34. | 1990 |
| Ettinger DS, Finkelstein DM, Abeloff MD, Chang YC, Smith TJ, Oken MM, Ruckdeschel JC. Phase II study of nmethylformamide (NSC 3051) and spirogermanium (NSC 192965) in the treatment of advanced small cell lung cancer. Invest New Drugs. 1990;9(2):183-85. | 1990 |
| Ruckdeschel JC. Attempts to enhance locoregional control of cancer by radiotherapy, phototherapy and combined modality therapy [invited review]. Curr Opin Oncol. 1989;1:231-5. | 1989 |
| Bonomi PD, Finkelstein DM, Ruckdeschel JC, Blum RH, Green MD, Mason B, Hahn R, Tormey DC, Harris J, Comis R, Glick J. Combination chemotherapy versus single agents followed by combination chemotherapy in stageIV non-small cell lung cancer (NSCLC): an Eastern Cooperative Oncology Group study. J Clin Oncol. 1989;7:1602-13. | 1989 |
| Ettinger DS, Finkelstein DM, Donehower RC, Chang AYC, Greene M, Blum R, Hahn RG, Ruckdeschel JC. A phase II study of n-methylformamide, spirogermanium and 4-demethoxydaunorubicin in the treatment of non-small cell lung cancer (EST 3583). An ECOG Study. Med Ped Oncol. 1989;17:197-201. | 1989 |
| Finkelstein DM, Cassileth BR, Bonomi PD, Ruckdeschel JC, Ezdinli EZ, Wolter JM. A pilot study of the functional living index-cancer (FLIC) scale for the assessment of quality of life for metastatic lung cancer patients: an Eastern Cooperative Oncology Group study. Am J Clin Oncol. 1988;11:630-33. | 1988 |
| Blanchard CG, Labrecque MS, Ruckdeschel JC, Blanchard EB. Information and decision-making preferences of hospitalized adult cancer patients. Soc Sci Med. 1988;27:1139-45. | 1988 |
| Ruckdeschel JC, Carney DN, Oie H, Russell EF, Gazdar AF. In vitro chemosensitivity of human lung cancer cell lines. Cancer Treat Rep. 1987;71:697-704. | 1987 |
| Trump DL, Elson P, Borden EC, Harris J, Tuttle R, Whisnant JK, Oken M, Carignan JR, Ruckdeschel JC, Davis TE. High dose lymphoblastoid interferon in advanced renal cell carcinoma. An Eastern Cooperative Oncology Group study. Cancer Treat Rep. 1987;71:165-69. | 1987 |
| Baker RR, Ettinger DS, Ruckdeschel JC, Eggleston JC, McKneally MF, Abeloff MD, Woll JE, Adelstein DJ. The role of surgery in the management of selected patients with small cell carcinoma of the lung. J Clin Oncol.1987;5:697-702. | 1987 |
| Blanchard CG, Ruckdeschel JC, Labrecque MS, Frisch S, Blanchard EB. The impact of a designated cancer unit on house staff behaviors toward patients. Cancer. 1987;60:2348-54. | 1987 |
| Ruckdeschel JC, Finkelstein DM, Ettinger DS, Creech RA, Mason RC, Joss BA, Vogl S A randomized trial of the four most active regimens for metastatic non-small cell lung cancer. J Clin Oncol. 1986;4:14-22. | 1986 |
| Finkelstein DM, Ettinger DS, Ruckdeschel JC. Long-term survivors in metastatic non-small cell lung cancer: an Eastern Cooperative Oncology Group study. J Clin Oncol. 1986;4:702-9. | 1986 |
| Blanchard CG, Ruckdeschel JC, Fletcher BA, Blanchard EB. The impact of oncologists behavior on patient satisfaction with morning rounds. Cancer. 1986;58:387-93. | 1986 |
| Cohen RE, Blanchard EB, Ruckdeschel JC, Smolen RC. Prevalence and correlates of post-treatment and anticipatory nausea and vomiting in cancer chemotherapy. J Psychosom Res. 1986;30:643-54. | 1986 |
| Funa K, Dawson N, Jewett PB, Agren H, Ruckdeschel JC, Bunn Jr PA, Gazdar AF. Automated fluorescent analysis for drug-induced cytotoxicity assays. Cancer Treat Rep. 1986;70:1147-51. | 1986 |
| Rodichok LD, Ruckdeschel JC, Harper GR, Cooper G, Prevosti L, Fernando L, Baxter DH. Early detection and treatment of spinal epidural metastases: the role of myelography Ann Neurol. 1986;20:696-702. | 1986 |
| Mulshine J, Glatstein E, Ruckdeschel JC Treatment of non-small cell lung cancer [invited review]. J Clin Oncol.1986;11:1704-15. | 1986 |
| Blanchard CG, Ruckdeschel JC. Psychosocial aspects of cancer in adults: implications for teaching medical students. J Cancer Educ. 1986;1:237-48. | 1986 |
| Ruckdeschel JC, Day R, Weissman CH, Stolbach LL, Creech RH. Chemotherapy for metastatic non-small cell bronchogenic carcinoma: cyclophosphamide, doxorubicin and etoposide versus mitomycin-vinblastine (EST 2575, generation IV). J Clin Oncol. 1985;3:72-9. | 1985 |
| Ruckdeschel JC, Finkelstein D, Creech RH, Mason BA. Chemotherapy for metastatic non-small cell bronchogenic carcinoma: EST 2575, general V: a randomized comparison of four cisplatin-containing regimens. J Clin Oncol. 1985;3:72-9. | 1985 |
| Vogl SE, Camacho F, Berenzweig M, Ruckdeschel JC. Chemotherapy for esophageal cancer with mitoguanazone, methotrexate, bleomycin and cisplatin. Cancer Treat Rep. 1985;69:21-3. | 1985 |
| O’Donnell MR, Ruckdeschel JC, Baxter D, McKneally MF, Caradonna R, Horton J. Intensive induction chemotherapy for small cell anaplastic carcinoma of the lung. Cancer Treat Rep. 1985;69:571-5. | 1985 |
| Bonomi P, O’Reilly W, Vogl SE, Ruckdeschel JC, Stolbach L, Bunting N, Creech RH. Intensive induction treatment of small cell bronchogenic carcinoma with cyclophosphamide, methotrexate and etoposide. Cancer Treat Rep.1985;69:1007-9. | 1985 |
| Ettinger DS, Finkelstein DM, Harper GR, Ruckdeschel JC, Chang AY, Camacho FJ, Marsh JC, Silber R, Wolter JM. Phase II study of mitoxantrone, aclarubicin and diaziquinone in the treatment of non-small cell lung carcinoma: an Eastern Cooperative Oncology Group study. Cancer Treat Rep. 1985;69:1033-4. | 1985 |
| Ahles T, Ruckdeschel JC, Blanchard EB. Cancer-related pain. I: prevalence in an outpatient setting as a function of stage of disease and type of cancer. J Psychosom Res. 1984;28:115-9. | 1984 |
| Zimmerman MS, Ruckdeschel JC, Hussain M. Chemotherapy-induced interstitial pneumonitis during treatment of small cell anaplastic lung cancer. J Clin Oncol. 1984;2:396-405. | 1984 |
| Ahles T, Ruckdeschel JC, Blanchard EB. Cancer-related pain. II: assessment with visual analogue scales. J Psychosom Res. 1984;28:121-4. | 1984 |
| Creech RH, Tritchler D, Ettinger DS, Ferraro JA, Ruckdeschel JC, Vogl SE, Woll J. Phase II study of PALA amsacrine, teniposide and zinostatin in small cell lung carcinoma (EST-2579). Cancer Treat Rep. 1984;68:1183-4. | 1984 |
| Spiers ASD, Ruckdeschel JC, Horton J. Effectiveness of pentostatin (2’-deoxyoformycin) in refractory lymphoid neoplasms. Scand J Haematol. 1984;32:130-4. | 1984 |
| Ettinger SD, Day R, Ferraro JA, Ruckdeschel JC, Woll JE, Vogl SE. A phase II study of AMSA (NSC 249992) and neocarzinostatin (NSC 157365) in non-small cell bronchogenic carcinoma: an Eastern Cooperative Oncology Group study. Am J Clin Oncol. 1983;6:167-70. | 1983 |
| Ahles TA, Blanchard EB, Ruckdeschel JC. The multidimensional nature of cancer-related pain. Pain. 1983;17:277-88. | 1983 |
| Blanchard CB, Ruckdeschel JC, Blanchard EB, Arena JG, Saunders NL, Malloy ED. Interactions between oncologists and patients during rounds. Ann Intern Med. 1983;99:694-9. | 1983 |
| Arsenau JC, Wolter JM, Juperminc M, Ruckdeschel JC. A phase II study of bruceantin (NSC-165, 563) in advanced malignant melanoma. Invest New Drugs. 1983;1:239-42. | 1983 |
| Cohen RE, Ruckdeschel JC, Blanchard CG, Rohrbaugh M, Horton J. Attitudes towards cancer. II: a comparative analysis of cancer patients, medical students, medical residents, physicians and cancer educators. Cancer. 1982;50:1218-23. | 1982 |
| Ruckdeschel JC, Lea JW, Brown S, Horton J. Content-bias in the neoplastic-related items of the national board of medical examiners part II examination. Med Pediatr Oncol. 1982;10:269-74. | 1982 |
| Blanchard C, Ruckdeschel JC, Cohen RE, Horton J, McSharry J, Shaw E. Attitudes towards cancer. I: the impact of a comprehensive oncology course on second year medical students. Cancer. 1981;47:2756-62. | 1981 |
| Lunia SL, Ruckdeschel JC, McKneally MF, Killam E, Baxter D, Kellar S, Ray P, McIlduff J, Lininger L, Chodos R, Horton J. Non-Invasive evaluation of mediastinal metastases in bronchogenic carcinoma: a prospective comparison of chest radiography and gallium-67 scanning. Cancer. 1981;47:672-9. | 1981 |
| Rodichok LD, Harper GR, Ruckdeschel JC, Price A, Roberson G, Barron KD, Horton J. Early diagnosis of spinal epidural metastases. Am J Med. 1981;70:1181-7. | 1981 |
| Ruckdeschel JC, Mehta CR, Salazar OM, Cohen M, Vogl S, Koons LS, Lerner H. Chemotherapy of inoperable non-small cell bronchogenic carcinoma. Cancer Treat Rep. 1981;65:965-72. | 1981 |
| Ruckdeschel JC, Mehta CR, Salazar OM, Cunningham TJ, Creech RH, Sponzo RW. Chemotherapy for metastatic non-small cell bronchogenic carcinoma: EST 2575 generation III, HAM vs CAMP. Cancer Treat Rep. 1981;65:959-63. | 1981 |
| Brandman J, Ruckdeschel JC, O’Donnell M, Horton J. Rapid tumor necrosis leading to serious pulmonary infections in patients treated intensively for small cell cancer of the lung. N Y State J Med. 1981;81:1332-4. | 1981 |
| Ruckdeschel JC, McKneally MF, Baxter DH, Devore C, Kellar S, Killam D, Caradonna R, Sedransk N, McIlduff J, Horton J. Regional immunotherapy has a detrimental effect on the response to combined irradiation and chemotherapy in locally advanced non-small cell bronchogenic carcinoma. Cancer Immunol Immunother. 1981;11:277-82. | 1981 |
| Ferraro JA, Horton J, Weissman C, Ruckdeschel JC, O’Donnell M, Ludlum D. Treatment of advanced colorectal carcinoma with AMSA. Cancer Treat Rep. 1981;65:345-7. | 1981 |
| Lempert N, MacDowell RT, Karmody A, Knight E, Cunningham TJ, Sponzo R, Horton J, Ruckdeschel JC. Vascular access for cancer chemotherapy. Cancer. 1979;43:1934-6. | 1979 |
| Caradonna R, Paladine W, Ruckdeschel JC, Goldstein JC, Olsen JE, Jaski JW, Silvers SA, Hillinger S, Horton J. Methotrexate, bleomycin and high dose cis-platinum for advanced epidermoid carcinoma of the head and neck Cancer Treat Rep. 1979;63:489-91. | 1979 |
| Ruckdeschel JC, Baxter DH, McKneally MR, Killan DA, Lunia SL, Horton J. Sequential radiotherapy and adriamycin in the management of bronchogenic carcinoma: the question of additive toxicity. Int J Radiat Oncol Biol Phys. 1979;5:1323-8. | 1979 |
Ruckdeschel JC, Lininger L, Brzyski H, Miani M, Becker J. Serial quantitation of in vitro lymphocyte
responsiveness to Concanavalin-A. Transplantation. 1979;28(3):203-6. | 1979 |
| Ruckdeschel JC, Caradonna R, Paladine WJ, Hillinger SM, Horton J. Small cell anaplastic carcinoma of the lung: changing concepts and emerging problems. CA Cancer J Clin. 1979;29:84-95. | 1979 |
| Ruckdeschel JC, Schimpff SC, Smyth AC, Mardiney Jr MR. Correlation of susceptibility to herpes zoster with impaired cell associated immunity to the varicella-zoster virus in patients with hodgkin’s disease. Am J Med. 1977;62:77-85. | 1977 |
| Ruckdeschel JC, Doukas J, Drake WP, Mardiney Jr MR. Application of laser cytometry to the analysis of immunologically induced in vitro lymphocyte blastogenesis. Transplantation. 1977;23:396-403. | 1977 |
| Doukas J, Ruckdeschel JC, Mardiney Jr MR. Quantitative and qualitative analysis of human peripheral lymphocyte proliferation to specific antigen in vitro by use of the helium neon laser. J Immunol Methods. 1977;15:229-38. | 1977 |
| Hahn DM, Schimpff SC, Ruckdeschel JC, Wiernik PH. Single-agent therapy for renal cell carcinoma: CCNU, vinblastine, thiotepa, or bleomycin. Cancer Treat Rep. 1977;61(8):1585-7. | 1977 |
| Ruckdeschel JC, Mardiney Jr MR. The demonstration of cell associated immunity to viruses. In vitro lymphocyte responsiveness to varicella-zoster antigen. J Immunol Methods. 1976;13:131-43. | 1976 |
| Graziano KD, Ruckdeschel JC, Mardiney Jr MR. Cell associated immunity to measles (rubeola): the demonstration of in vitro lymphocyte tritiated thymidine incorporation in response to measles complement fixation antigen. Cellular Immunol. 1975;15:247-359. | 1975 |
| Ruckdeschel JC, Graziano, KD, Mardiney Jr MR. Additional evidence that the cell associated immune system is the primary host defense against measles (rubeola). Cell Immunol. 1975;17:11-18. | 1975 |
| Ruckdeschel JC, Chang P, Martin RG, Byhardt RW, O’Connell MJ, Sutherland JC, Wiernik PH. Radiation-related pericardial effusions in patients with Hodgkin’s disease. Medicine (Baltimore). 1975;54:245-59. | 1975 |
| Byhardt RW, Brace K, Ruckdeschel JC, Chang P, Martin RW, Wiernik PH. Dose and treatment factors in radiation related pericardial effusion associated with the mantle technique for hodgkin’s disease. Cancer. 1975;35:795-802. | 1975 |
| Martin RW, Ruckdeschel JC, Chang P, Byhardt RW, Bouchard P, Wiernik PH. Radiation-related pericarditis. Am J Cardiol. 1975;35:216-20. | 1975 |
| Dummire C, Ruckdeschel JC, Mardiney Jr MR. Suppression of in vitro lymphocyte responsiveness to PPD by measles virus: a re-exploration of the phenomenon. Cell Immunol. 1975;20:205-17. | 1975 |
| Drake WP, Porkorney DR, Ruckdeschel JC, Levy CC, Mardiney Jr MR A white blood cell ribonuclease assay for the monitoring of malignancy. J Natl Cancer Inst. 1975;54:1475-78. | 1975 |
| Ruckdeschel JC, Kramarsky B, Mardiney Jr MR. Mycoplasma contamination of membrane associated measles antigens. Inability to demonstrate in vitro lymphocyte responsiveness to measles. Cell Immunol. 1975;20:110-16. | 1975 |
| Ruckdeschel JC, Codish SD, Stranahan A, McKneally MF. Postoperative empyema improves survival in lung cancer. Documentation and analysis of a natural experiment. N Engl J Med. 1972;287:1013-7. | 1972 |
| Ruckdeschel JC, Peters T, Lee KT. Fibrinogen catabolism in rats fed thrombogenic diets. Atherosclerosis. 1972;16:277-85. | 1972 |
| Sklarin NT, Wiernik PH, Grove WR, Benson L, Mittelman A, Maroun JA, Steward JA, Robert F, Doroshow JH, Rosen PJ, Jolivet J, Ruckdeschel JC, Robert NJ, Velez-Garcia E, Bergsagel DE, Panasci LC, van der Merwe AM, Longueville JJ, Leiby J. A phase II trial of CI-921 in advanced malignancies. Invest New Drugs. 1992;10:309-12. | |
Book Chapter |
| Ruckdeschel JC At the Core of Oncology The Art and Science of Oncology. Boston (MA): Aspatore Books; 2007, pp33-44 | |
Ruckdeschel JC
Abeloff M, Armitage J, and Niederhuber J Lung cancer Clinical Oncology. Philadelphia: Churchill-Livingstone; 2004. p.1649-743. | |
Ruckdeschel JC
Abeloff M, Armitage J, and Niederhuber J Spinal cord compression Clinical Oncology. Philadelphia: Churchill-Livingstone; 2004. p.1063-71. | |
Book |
| Helft PR, Albrecht TL, Back A, Ruckdeschel JC. Challenges to physician communication about treatment options to patients. ASCO Educational Book Alexandria: American Society of Clinical Oncology; 2006 | |
| Ruckdeschel JC Myths and facts about lung cancer. What You Need to Know Melville (NY): PRR Publishers; 2004. | |
| Ruckdeschel JC Update in the management of lung cancer New York (NY): RogersMIS. 2004;3(2) | |
| Ninane V, LePechoux C, Curran W, Furuse K, Liptay M, Meert AP, Paesmans M, Rami-Porta R, Roelandts R, Ruckdeschel JC, Sculier JP, Senan S, Smit EF Critical factors for patient management Lung Cancer. 2003;42(suppl):57-8. | |
| Alberts WM, Bepler G, Hazelton T, Ruckdeschel JC, Williams Jr JH Practice organization Chest. 2003;123(suppl 1):2202-5. | |
Ruckdeschel JC, Greene J, Sommers KE, Fields KK
Kufe DW, Holland JF, Frei E, Respiratory complications of cancer and its treatment Cancer Medicine 6. Hamilton (ON); Lewiston (NY) [distributor]: BC Decker. 2003. | |
Albrecht TA, Blanchard CG, Ruckdeschel JC, Coovert MA
Brashers D, Goldsmith D, and Lammers L The mediating role of communication in cancer treatment decision making Communication in the management of health and illness. Manwah (NJ): Lawrence Erlbaum & Associates. In press. | |
| Robinson LA, Wagner H, Ruckdeschel JC Lung cancer guidelines, treatment of stage IIIA non-small cell lung cancer Chest. 2003;123(suppl 1): 3325-75. | |
| Ruckdeschel JC Myths and facts about lung cancer: What You Need to Know Melville (NY): PRR Publishers; 2002. | |
Ruckdeschel JC, Jablons D
Kirkwood JM, Lotze MT, Yasko JM Malignant effusions of the chest Cancer Therapeutics. 4th ed. Philadelphia: Current Medicine; 2001. | |
Ruckdeschel JC, Robinson L
Berger, Portenoy, Weissman Management of pleural and pericardial effusions Lung cancer; principles and practice of palliative care and supportive oncology. Philadelphia: Lippincott,Williams & Wilkins. In press 2001 | |
| Simon G, Ginsberg R, Ruckdeschel JC Small cell lung cancer Chest Surg Clin N Am. 2001;11(1):165-8. | |
Ruckdeschel JC
Ratain MJ, Tempero M, Skosey C Intrapleural therapy Oncology therapeutics: a quick reference guide. Philadelphia: WB Saunders; 2000 | |
Blanchard C, Albrecht T, Ruckdeschel JC
Bader, Cooper, DeNour Patient family communication with physicians Cancer and the family. 2nd ed. West Sussex (England): John Wiley & Sons, Ltd; 2000. p.477-95. | |
| Ruckdeschel JC Myths and facts about lung cancer: What You Need to Know Melville (NY): PRR Publishers; 1999. | |
| Yanes B, Bonomi PD, Curran Jr WJ, Ginsberg RJ, Khuri FR, Ruckdeschel JC, Weiland JE Advances in lung cancer management: 1997 Miami Valley hospital lung conference [monograph] Bristol Myers Squibb, 1998 | |
Tockman M, Ruckdeschel JC, Mulshine J
Jett J The early detection of second primary lung cancers by sputum immunostaining Current clinical trials in thoracic oncology - what the chest physician needs to know. 1998;2(1):3,8-9. | |
Ruckdeschel JC
Abeloff M, Armitage J, Lichter A, Niederhuber J Spinal cord compression Clinical Oncology. 2nd ed. New York: Churchill Livingstone; 1999. p.811-9. | |
| Ruckdeschel JC Chemotherapy for lung cancer: new agents with significant benefit Primary Care & Cancer. 1998;18(5):26-32. | |
Mackey CS, Ruckdeschel JC
Sullivan P, Guilford AM Lung cancer Swallowing Intervention in Oncology. San Diego: Singular Publishing; 1999. p.117-33. | |
| Ruckdeschel JC, Aisner J, Evans W, Gandara D, Green M, Holmes EC, Ihde DC, Johnson DH, Sause WT, Wagner Jr H Commentary and review of presentations on lung cancer [monograph] Bristol Myers Squibb, 1998 | |
Ruckdeschel JC
Kirkwood JM, Lotze MT, Yasko JM Malignant effusions in the chest Current Cancer Therapeutics, 3rd ed. New York: Churchill Livingstone; 1998. p.324-8. | |
Ruckdeschel JC
Jett J A prospective randomized trial of bleomycin vs doxycycline vs talc for the intrapleural treatment of malignant pleural effusions. Current clinical trials in thoracic oncology - what the chest
physician needs to know. 1997;1(3). | |
| Ruckdeschel JC, Aisner J, Ettinger D, Jett J, Wagner H Current approaches to managing patients with small cell lung cancer [monograph] Smith Kline Beecham, 1997 | |
Garland LL, Ruckdeschel JC, Wagner Jr H, Williams Jr C, Shaw G, Antonia S, Heise M, Hilstro J, Cantor A
Johnson, Klastersky Single agent paclitaxel as second-line chemotherapy for resistant, metastatic non-small cell lung cancer Taxanes in lung cancer therapy. New York: Marcel Dekker, Inc.; 1998. p.117-26. | |
Ruckdeschel JC
Roth JA, Cox JD, Hong WK Preoperative and postoperative adjunctive therapy for resectable non-small cell lung cancer Lung Cancer. 2nd ed. Boston: Blackwell Scientific; 1997. p.207-16. | |
| Bonomi P, Ruckdeschel JC New approaches in the treatment of stage IV non-small cell lung cancer [monograph] Bristol Myers Squibb, 1997. | |
| Ruckdeschel JC Editorial overview: lung and mediastinum Curr Opin Oncol. 1997;9(2):147-8 | |
Antonia S, Robinson LA, Ruckdeschel JC, Wagner H
Balducci, Lyman, Ersher Lung cancer Comprehensive geriatric oncology. 2nd ed. London: Harwood Academic Publishers; 1997. p.613-30. | |
| Ruckdeschel JC Treating lung cancer Coping. 1997;38-9 | |
Robinson L, Ruckdeschel JC
Berger, Portenoy, Weissman Management of pleural and pericardial effusions Lung cancer: principles and practice of supportive oncology. Philadelphia: JB Lippincott; 1998. p.327-52 | |
| Ruckdeschel JC Combined modality therapy of non-small cell lung cancer Semin Oncol. 1997;24(4):429-39 | |
| Ruckdeschel JC, Robinson L Malignant pleural effusions: questions and controversies [monograph] Bristol Myers Squibb, 1997. | |
Ruckdeschel JC
Semendinger Breaking clinical and administrative barriers The challenge of health care leadership. Chicago: AHA Publishing; 1997. p.51-68. | |
| Ruckdeschel JC, Wagner H, Robinson L Cáncer de Pulmón Localmente Avanzado [Locally Advanced Lung Cancer] (Spanish) Revista argentina cancerología. 1996;24(2):90-2 | |
| Ruckdeschel JC, Wagner H, Robinson L Locally advanced lung cancer: controversies in management Advances in Oncology. 1996;12(3):22-8 | |
| Ruckdeschel JC, Wagner H, Robinson L Locally advanced lung cancer - controversies in management ASCO Educational Book, 1996. | |
| Ruckdeschel JC Malignant pleural effusion: a cost-effectiveness analysis of pleurodesis [monograph] Bristol Myers Squibb, 1996. | |
Ruckdeschel JC
Kirkwood JM, Lotze MT, Yasko JM Malignant effusions in the chest Current cancer therapeutics. 2nd ed. Philadelphia: Churchill-Livingstone; 1996. p.304-8. | |
| Ruckdeschel JC, Aisner J, Ettinger DS, Johnson DH, Wagner H Small cell lung cancer [monograph] Bristol Myers Squibb, 1995. | |
| Ruckdeschel JC Introduction: LCSG - the final analysis Chest. 1994;106(6):279s. | |
Blanchard C, Ruckdeschel JC, Albrecht T
Bader, Cooper, DeNour Patient-family communication with physicians Cancer and the family. West Sussex : John Wiley & Sons; 1996. p.369-87. | |
Wagner H, Ruckdeschel JC
Reintgen D, Clark RA Screening, early detection and early intervention strategies for cancer of the respiratory system (lung and bronchus) Cancer screening. St. Louis: Mosby Year Book; 1995. p.118-49. | |
Moores D, Ruckdeschel JC
Roth J, Ruckdeschel J, Weisenburger T Pleural effusions in patients with malignancy Thoracic Oncology II. Philadelphia: WB Saunders; 1995. p.556-66. | |
Williams C, Ruckdeschel JC
Roth J, Ruckdeschel J, Weisenburger T Management of disseminated non-small cell lung cancer Thoracic Oncology II. Philadelphia: WB Saunders; 1995. p.181-7. | |
Ruckdeschel JC
Roth J, Weisenburger T Lung cancer: an overview Thoracic Oncology II. Philadelphia: WB Saunders; 1995. p.3-4. | |
| Ruckdeschel JC Future directions in non-small cell lung cancer-a personal view Lung cancer. 1995;12(2):s147- 52. | |
| Ruckdeschel JC Current status and future role of carboplatin [monograph] Bristol-Myers Squibb, 1994. | |
Ruckdeschel JC, Robinson LA
Pass H, Mitchell D, Johnson A, Turrisi J Non-small cell lung cancer: surgery and postoperative adjuvant chemotherapy Lung cancer: principles & practice. Philadelphia: JB Lippincott; 1996. P.839-49. | |
Ruckdeschel JC
Rakel R Carcinoma of the lung current therapy Conn’s current therapy. Philadelphia: WB Saunders; 1994. p.156-63. | |
Ruckdeschel JC
Abeloff M, Armitage J, Lichter A, Niederhuber J Spinal cord compression due to cancer: early diagnosis and treatment Clinical oncology. New York: Churchill Livingstone; 1995. p. 619-28. | |
| Ruckdeschel JC The future role of carboplatin Semin Oncol. 1994;21(5):114-8. | |
Ruckdeschel JC
Roth J, Cox J, Hong WK Preoperative and postoperative adjunctive therapy for resectable non-small cell lung cancer Lung cancer. Boston: Blackwell Scientific Publications; 1993. p. 239-51. | |
| Wagner H, Ruckdeschel JC Treatment of locally advanced and metastatic non-small cell lung cancer Advances in Oncology. 1993;9(5):22-9. | |
| Ruckdeschel JC The role of standard dose etoposide in the management of non-small cell lung cancer Semin Oncol. 1992;19(6):39-44. | |
| Ruckdeschel JC Lung cancer - 1993 Mediguide to oncology. 1994;14(1):1-8. | |
| Remick SC, Wagner H, Ruckdeschel JC Management of the patient with HIV-associated lymphomas and hodgkins disease AIDS reader. 1991;1:204-13. | |
Ruckdeschel JC A comparative overview of non-small cell lung cancer: 1980 v 1991 Lung cancer.
1993;9(suppl):15-24. | |
| Moffett MJ, Ruckdeschel JC Bleomycin and tetracycline in malignant pleural effusions Semin Oncol.1992;19(suppl):59-62. | |
| Ruckdeschel JC Current surgical approach to non-small cell lung cancer” by McCormack P [invited commentary] Oncology. 1991;5(11):44-6. | |
Holmes EC, Ruckdeschel JC
Pass H Postoperative chemotherapy for non-small cell lung cancer Chest Clinics of North America. 1991;1(1):89-97. | |
Ruckdeschel JC, Holmes EC
Pass H Preoperative chemotherapy for locally advanced non-small cell lung cancer Chest Clinics of North America. 1991;1:1-12. | |
| Ruckdeschel JC Malignant pleural effusions: recent advances in diagnosis and management Bristol-Myers Squibb; 1992. | |
| Ruckdeschel JC Etoposide in the management of non-small cell lung cancer Cancer. 1991;67(suppl):250. | |
Blanchard CG, Ruckdeschel JC
Roth J, Ruckdeschel J, Weisenburger T Quality of life Textbook of Thoracic Oncology. Philadelphia, PA: WB Saunders; 1989. p. 681-6. | |
Mulshine J, Ruckdeschel JC
Roth J, Ruckdeschel J, Weisenburger T The role of chemotherapy in the management of disseminated non-small cell lung cancer Textbook of thoracic oncology. Philadelphia, PA: WB Saunders; 1989. p 220-8. | |
Ruckdeschel JC
Roth J, Ruckdeschel J, Weisenburger T Lung cancer: an introduction Textbook of Thoracic Oncology. Philadelphia, PA: WB Saunders; 1989. p 2-5. | |
| Ruckdeschel JC Clinical advances in management of malignant pleural effusions J Crit Illn. 1988. | |
Ruckdeschel JC
Bitram J, Golomb H Chemotherapy of disseminated non-small cell lung cancer Lung cancer: a comprehensive treatise. New York, NY: Grune & Stratton; 1988. p 233-41. | |
| Ruckdeschel JC Management of malignant pleural effusions Semin Oncol. 1988;15(3 suppl 3):24-8. | |
Ruckdeschel JC
Kimura K, Ota K, Heberman RB, Takita H Chemotherapy of non-small cell lung cancer Cancer chemotherapy: challenges for the future, vo. 2. pp 202-209, Eds. K. Kimura, K. Ota, R.B. Heberman, H. Takita. Tokyo: Excerpta Medica; 1987. p 202-209. | |
Ruckdeschel JC, Oie HK, Gazdar AF
Hansen HH,Nijhoff M In vitro characterization of non-small cell lung cancer Lung cancer: basic and clinical aspects. Boston: Kluwer; 1986. p. 49-59. | |
| Muggia FM, Goldin A, Ruckdeschel JC New drugs in lung cancer Proceedings of the 4th Mediterranean Congress of Chemotherapy; 1984 Oct 19-25; Rhodes, Greece. Chemioterapia. 1984;4(2 Suppl):1138-9. | |
Ruckdeschel JC, Blanchard CG, Blanchard EB
Hurst W Direct measurement of physician behavior as a potential method of evaluating medical education Teaching internal medicine. 1984. | |
Ruckdeschel JC, Balint J, Gross P, Laufer F
Hurst W Instructional costs for full-time faculty in an academic department of internal medicine Teaching internal medicine. 1984. | |
Ruckdeschel JC
Schimpff S, Moossa AR, Robson MC Immunotherapy of Human Cancer: An Overview Comprehensive Textbook of Oncology. Baltimore: Willliams and Wilkins Publishers; 1984. | |
| Ruckdeschel JC Lung cancer - mediguide to oncology 1981;1(6) | |
| Ruckdeschel JC Diagnosis and management of small cell anaplastic (oat cell) cancer of the lung Current concepts in oncology. 1979;1:18-24. | |
Ruckdeschel JC, Lininger L, Brzyski H, Miani M, Becker J
Baum S Re-analysis of in vitro lymphocyte blastogenesis using the laser cytometry assay Experimental hematology today. Farmington, CT: Karger; 1979.p.123-8. | |
Book Review |
| Ruckdeschel JC IASLC proceedings - future directions in non-small cell lung cancer: a continuing perspective [review] Oncology. 1998;12(2):90-6. | |
| Ruckdeschel JC Comprehensive textbook of oncology [review] J Natl Cancer Inst. 1992;84:1596-7. | |
Ruckdeschel JC
Arriagada R, LeChevalier Treatment modalities in lung cancer J Natl Cancer Inst. 1989; 8:633-4. | |
Editorial Commentary |
| Ruckdeschel JC. Is chemotherapy for metastatic non-small cell lung cancer “worth it?” J Clin Oncol. 1990;8:1293-6. | 1990 |
| Ruckdeschel JC. Whither screening for lung cancer [editorial]. J Natl Cancer Inst. 1988;80:78-9. | 1988 |
| Ruckdeschel JC We have met the enemy . . . and they is us! [commentary] Curr Opin Oncol. 1996;8:103-5. | |
| Ruckdeschel JC The cost of success in the treatment of thoracic malignancies [commentary] Curr Opin Oncol. 1995;7:131-3. | |
| Ruckdeschel JC Early diagnosis of lung cancer [editorial] Clinical Cancer Briefs. 1981;2:2. | |
Letter to the Editor |
| Mardiney Jr MR, Ruckdeschel JC. Inhibition of in vitro lymphocyte response by measles virus antigen: a reply [letter]. Cell Immunol. 1977;28:229. | 1977 |
| Ruckdeschel JC Chemotherapy in metastatic lung cancer: Reply [letter] J Clin Oncol. 1986;4:1151-2. | |
| Ruckdeschel JC Amantadine and pulmonary peripheral airways [letter] Ann Int Med. 1977;86:369-70. | |
| Ruckdeschel JC, Wiernik PH Reactions to radiation therapy [letter] N Engl J Med. 1975;293:668-9. | |
| Ruckdeschel JC Tumor registries [letter] JAMA. 1973;266-72 | |